News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Waddill William D.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| Waddill William D. (Director) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 24,000 options to buy
@ $2.88, valued at
$69.1k
|
|
| 01/18/2023 |
4
| Waddill William D. (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 30,000 options to buy
@ $12.17, valued at
$365.1k
|
|
| 01/11/2023 |
4
| Waddill William D. (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 3,200 shares
@ $30, valued at
$96k
Granted 7,867 shares
@ $0
Granted 4,593 options to buy
@ $33.03, valued at
$151.7k
|
|
| 06/13/2022 |
4
| Waddill William D. (Director) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 24,000 options to buy
@ $3.84, valued at
$92.2k
|
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2022 |
4
| Waddill William D. (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Granted 6,400 shares
@ $0 |
|
| 01/04/2022 |
4
| Waddill William D. (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 2,100 shares
@ $64.23, valued at
$134.9k
Sold 2,128 shares
@ $65.01, valued at
$138.3k
Sold 272 shares
@ $66.25, valued at
$18k
|
|
| 08/16/2021 |
4
| Waddill William D. (Director) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 20,000 options to buy
@ $19.73, valued at
$394.6k
|
|
| 08/16/2021 |
3
| Waddill William D. (Director) has filed a Form 3 on Annexon, Inc. |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/11/2020 |
4
| Waddill William D. (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 1,200 shares
@ $68.5, valued at
$82.2k
Sold 1,800 shares
@ $73.1, valued at
$131.6k
|
|
| 05/29/2020 |
4
| Waddill William D. (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 15,000 options to buy
@ $16.54, valued at
$248.1k
|
|
| 05/13/2020 |
4
| Waddill William D. (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 26,000 shares
@ $36.54, valued at
$950k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2019 |
4
| Waddill William D. (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 12,000 options to buy
@ $11.8, valued at
$141.6k
|
|
| 01/11/2019 |
4
| Waddill William D. (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 8,500 shares
@ $14.77, valued at
$125.5k
|
|
| 01/03/2019 |
4
| Waddill William D. (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Granted 30,000 shares
@ $0 |
|
| 06/12/2018 |
4
| Waddill William D. (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 12,000 options to buy
@ $6.98, valued at
$83.8k
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2017 |
3
| Waddill William D. (Director) has filed a Form 3 on ARROWHEAD PHARMACEUTICALS, INC. |
| 05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/15/2016 |
4
| Waddill William D. (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 24,000 options to buy
@ $12.88, valued at
$309.1k
|
|
| 08/10/2016 |
3
| Waddill William D. (Director) has filed a Form 3 on Protagonist Therapeutics, Inc |
| 01/21/2016 |
4
| Waddill William D. (SR. VP & CFO) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 70,000 options to buy
@ $4.71, valued at
$329.7k
Granted 70,000 options to buy
@ $4.71, valued at
$329.7k
|
|
| 07/16/2015 |
4
| Waddill William D. (SR. VP & CFO) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Exercised 13,125 options to buy
@ $2.64, valued at
$34.7k
|
|
| 02/12/2015 |
4
| Waddill William D. (SR. VP & CFO) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 45,000 options to buy
@ $16.4, valued at
$738k
|
|
| 12/18/2014 |
4
| Waddill William D. (SENIOR VP & CFO) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Exercised 5,626 shares
@ $2.64, valued at
$14.9k
Exercised 1,171 shares
@ $7.2, valued at
$8.4k
Exercised 5,626 options to buy
@ $2.64, valued at
$14.9k
Exercised 1,171 options to buy
@ $7.2, valued at
$8.4k
|
|
| 07/23/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/19/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/17/2013 |
3
| Waddill William D. (SVP & CFO) has filed a Form 3 on OncoMed Pharmaceuticals Inc |
|
|